Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health
Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-r...
Main Authors: | O'Day, Elizabeth, Hosta-Rigau, Leticia, Oyarzún, Diego A., Okano, Hideyuki, de Lorenzo, Víctor, von Kameke, Conrad, Alsafar, Habiba, Cao, Cong, Chen, Guo-Qiang, Ji, Weizhi, Roberts, Richard J., Ronaghi, Mostafa, Yeung, Karen, Zhang, Feng, Lee, Sang Yup |
---|---|
Other Authors: | McGovern Institute for Brain Research at MIT |
Format: | Article |
Language: | English |
Published: |
Wiley
2020
|
Online Access: | https://hdl.handle.net/1721.1/126515 |
Similar Items
-
The power of synthetic biology for bioproduction, remediation and pollution control
by: De Lorenzo, Victor, et al.
Published: (2020) -
Topography: A Biophysical Approach to Direct the Fate of Mesenchymal Stem Cells in Tissue Engineering Applications
by: Xingli Cun, et al.
Published: (2020-10-01) -
Novel scaffold platforms for simultaneous induction osteogenesis and angiogenesis in bone tissue engineering: a cutting-edge approach
by: Arezoo Saberi, et al.
Published: (2023-09-01) -
Argentina’s Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?
by: Dalia Marcela Lewi, et al.
Published: (2020-04-01) -
Nanoparticles: Excellent Materials Yet Dangerous When They Become Airborne
by: Xiao-Hui Yin, et al.
Published: (2022-01-01)